IDH3A Protein

IDH3A — Isocitrate Dehydrogenase 3 Alpha

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">IDH3A Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Isocitrate Dehydrogenase 3 Alpha</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/idh3a">IDH3A</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P00343">P00343</a></td></tr>
<tr><td><strong>PDB IDs</strong></td><td>3LC4, 5Y24, 6OXE</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>45 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Mitochondria (matrix)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Isocitrate dehydrogenase family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Retinitis Pigmentosa, Leigh Syndrome, Stroke</td></tr>
</table>
</div>

Overview

IDH3A (Isocitrate Dehydrogenase 3 Alpha) is a mitochondrial enzyme that catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid (TCA) cycle. Unlike its paralogs IDH1 (cytosolic) and IDH2 (mitochondrial NADP+-dependent), IDH3A is NAD+-dependent and functions as a heterotetramer composed of α, β, and γ subunits. The enzyme is essential for oxidative energy metabolism in neurons and other tissues with high metabolic demands.

Structure

Subunit Composition

IDH3A — Isocitrate Dehydrogenase 3 Alpha

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">IDH3A Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Isocitrate Dehydrogenase 3 Alpha</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/idh3a">IDH3A</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P00343">P00343</a></td></tr>
<tr><td><strong>PDB IDs</strong></td><td>3LC4, 5Y24, 6OXE</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>45 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Mitochondria (matrix)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Isocitrate dehydrogenase family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Retinitis Pigmentosa, Leigh Syndrome, Stroke</td></tr>
</table>
</div>

Overview

IDH3A (Isocitrate Dehydrogenase 3 Alpha) is a mitochondrial enzyme that catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid (TCA) cycle. Unlike its paralogs IDH1 (cytosolic) and IDH2 (mitochondrial NADP+-dependent), IDH3A is NAD+-dependent and functions as a heterotetramer composed of α, β, and γ subunits. The enzyme is essential for oxidative energy metabolism in neurons and other tissues with high metabolic demands.

Structure

Subunit Composition

IDH3A forms a heterotetramer with α, β, and γ subunits:

• IDH3α (encoded by IDH3A): Catalytic subunit
• IDH3β (encoded by IDH3B): Regulatory subunit
• IDH3γ (encoded by IDH3G): Regulatory subunit

Catalytic Mechanism

The enzyme catalyzes: Isocitrate + NAD+ → α-Ketoglutarate + NADH + CO2[@pietrak2021]. This is a rate-limiting step in the TCA cycle.

Structural Features

• NAD+-dependent dehydrogenase activity
• Sensitivity to adenine nucleotides (ATP inhibits, ADP activates)
• Calcium-binding capacity for activity regulation

Normal Function

TCA Cycle Operation

IDH3A is one of three subunits that form the active IDH3 heterotetramer. The enzyme catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate, generating NADH for the electron transport chain.

Metabolic Regulation

IDH3A activity is regulated by:

• ADP: Activator, stimulates catalytic activity
• ATP: Inhibitor, provides feedback on energy status
• NADH: Inhibitor, reflects cellular redox state
• Calcium: Activator, linking enzyme activity to neuronal activity

Brain Energy Metabolism

In neurons, IDH3A is crucial for oxidative phosphorylation and ATP production. Neurons rely heavily on oxidative metabolism, making IDH3A function essential for neuronal survival and function.

Role in Disease

Retinitis Pigmentosa

IDH3A mutations cause autosomal dominant retinitis pigmentosa, characterized by progressive photoreceptor degeneration[@kim2019]. The retina has high metabolic demands, and IDH3A dysfunction impairs retinal energy metabolism, leading to photoreceptor cell death. Key features include:

• Night blindness: Initial symptom due to rod photoreceptor dysfunction
• Tunnel vision: Progressive visual field constriction
• Complete blindness: End-stage disease

Leigh Syndrome

IDH3A deficiency can cause Leigh syndrome, a progressive neurodegenerative disorder characterized by bilateral basal ganglia lesions, developmental regression, and respiratory failure[@chen2020]. Features include:

• Basal ganglia lesions: Characteristic MRI findings
• Developmental regression: Loss of previously acquired milestones
• Respiratory failure: Central apnea and respiratory dysfunction
• Seizures: Common neurological manifestation

Stroke and Ischemia

IDH3A activity decreases during cerebral ischemia, contributing to impaired energy metabolism and increased neuronal death[@sevigny2020]. The enzyme's sensitivity to oxygen and glucose deprivation makes neurons vulnerable to IDH3A dysfunction. Therapeutic strategies include:

• Metabolic support: Enhancing alternative energy pathways
• Ischemic preconditioning: Upregulating protective metabolic responses

Cancer

While IDH3A mutations are relatively rare in cancer, mutations in IDH1 and IDH2 are common. The metabolic rewiring caused by IDH mutations provides survival advantages to cancer cells[@ye2018]:

• Oncometabolite production: 2-hydroxyglutarate accumulation
• Epigenetic dysregulation: DNA and histone hypermethylation
• Cellular dedifferentiation: Blocked differentiation programs

Expression

Tissue Distribution

IDH3A is expressed in tissues with high metabolic demands:

• Retina: Photoreceptors have extremely high energy requirements
• Brain: Neurons rely on oxidative metabolism
• Heart: Continuous energy demand for cardiac function
• Skeletal muscle: High metabolic activity during exercise

Cellular Localization

Within cells, IDH3A is localized to the mitochondrial matrix, where it participates in TCA cycle function. The enzyme's activity is coupled to oxidative phosphorylation through NADH production.

Therapeutic Targeting

Gene Therapy

Viral vector-mediated IDH3A delivery to retinal cells represents a potential treatment for IDH3A-associated retinitis pigmentosa.

Metabolic Modulators

Compounds that enhance mitochondrial function or bypass IDH3A deficiency may have therapeutic utility in Leigh syndrome and related disorders.

See Also

• [IDH3A Gene](/genes/idh3a)
• [TCA Cycle](/mechanisms/citric-acid-cycle)
• [Mitochondria](/entities/mitochondrial-dna)
• [Retinitis Pigmentosa](/diseases/retinitis-pigmentosa)
• [Leigh Syndrome](/diseases/leigh-syndrome)

References